Business Wire

Gilead Canada Announces Notice of Compliance for DESCOVY® (emtricitabine, tenofovir alafenamide) for HIV Pre-Exposure Prophylaxis (PrEP)

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Gilead Sciences Canada, Inc. (Gilead Canada) today announced that Health Canada has granted a Notice of Compliance (NOC) for DESCOVY® (emtricitabine 200 mg and ...
Nasdaq

Gilead Presents New Findings on Profile of Descovy® for Potential Use as HIV Pre-exposure Prophylaxis Compared With Truvada®

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (NASDAQ: GILD) today presented additional results from the DISCOVER trial evaluating an investigational use of Descovy (emtricitabine 200 ...
Nasdaq

Gilead Submits Supplemental New Drug Application to U.S. Food and Drug Administration for Once-Daily Descovy® for HIV Pre-Exposure Prophylaxis

FOSTER CITY, Calif.-- (BUSINESS WIRE)-- Gilead Sciences, Inc. (NASDAQ: GILD) announced today that the company has submitted a supplemental New Drug Application (sNDA) to the U.S. Food and Drug ...
Bay Area Reporter

LGBTQ Agenda: Counterfeiting ring sold fake Biktarvy, Descovy, Gilead says

Gilead Sciences Inc. announced that almost 100,000 bottles of its HIV medications had been faked or tampered with over the past two years. According to a lawsuit unsealed by a federal judge in the ...
Yahoo

Gilead: Two of Our HIV Drugs Were Tampered With

Gilead has announced that there have been tampered with and counterfeit versions of the company’s HIV treatment drug Biktarvy and its HIV treatment and prevention drug Descovy circulating in the U.S.
Monthly Prescribing Reference

Descovy for PrEP Continues to Be Noninferior to Truvada, According to 96 Week Data

Descovy demonstrated continued noninferiority to Truvada for HIV pre-exposure prophylaxis and statistically significant differences over Truvada for pre-specified secondary end points. In the phase 3, ...
Drug Store News

Lupin receives FDA nod for generic Descovy

The drug is indicated for the treatment of HIV-1 infection and for pre-exposure prophylaxis to reduce the risk of HIV-1 infection in adults and adolescents. Lupin has received approval from the Food ...
Monthly Prescribing Reference

FDA Approves Descovy for the Treatment of HIV-1

Gilead Sciences announced that the FDA has approved Descovy (emtricitabine/tenofovir alafenamide [F/TAF]) tablets for the treatment of HIV-1 infection. Gilead Sciences announced that the Food and Drug ...
LGBTQ Nation

Gilead warns that counterfeit versions of its HIV meds are being found in U.S. pharmacies

U.S. pharmacies are selling counterfeit versions of HIV medication, according to the biopharmaceutical company Gilead Sciences. Specifically, Gilead warned that knock-off versions of its Biktarvy and ...
Pharmabiz

Lupin receives US FDA approval for emtricitabine and tenofovir alafenamide tablets

Global pharma major Lupin Limited (Lupin) announced that it has received approval from the United States Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for ...
Newsweek

Counterfeit HIV Medications Hit U.S. Pharmacies, Drug Manufacturer Warns

Gilead Sciences, the manufacturer of multiple pharmaceuticals, including HIV medications Biktarvy and Descovy, has issued a warning that it has become aware of counterfeit versions of these drugs ...
Today

Government can’t mandate coverage for drugs that prevent HIV infections, Texas federal judge rules

A federal judge in Texas has ruled that a provision of the Affordable Care Act that mandates free coverage of certain drugs that prevent HIV infections violate the religious beliefs of a ...